Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elisabeth Letellier is active.

Publication


Featured researches published by Elisabeth Letellier.


Revue de Médecine Interne | 2006

Prééclampsie et syndrome des antiphospholipides. Intérêt du Doppler utéroplacentaire

Lionel Carbillon; M. Uzan; A. Kettaneh; Elisabeth Letellier; J. Stirnemann; Nicolas Perrot; A. Tigaizin; Olivier Fain

INTRODUCTIONnWomen with persistently high resistance in uterine arteries have an increased risk of the subsequent development of preeclampsia. Doppler investigation provides a non-invasive method for the study of the uteroplacental blood flow. In pregnant women the antiphospholipid syndrome is associated to an increased risk of preeclampsia and complications related to uteroplacental insufficiency, and the role of uterine artery Doppler is discussed.nnnCURRENT KNOWLEDGE AND KEY POINTSnIn normal pregnancy, impedance to flow in the uterine arteries decreases with gestation, as the likely consequence of the physiologic change of spiral arteries into low-resistance vessels. In women with preeclampsia or related complications, the abnormal persistence of high resistance to flow in the uterine arteries correlates with maternal and neonatal outcome. In one study including patients with antiphospholipid syndrome, a high resistance index in the uterine arteries at 22-24 weeks gestation strongly predicted the subsequent development of preeclampsia. In another study including patients with lupus anticoagulant, persistent bilateral notches at 22-24 weeks gestation may identify preeclampsia and fetal growth restriction with a high sensitivity, specificity, positive and negative predictive value. The treatment may improve the uteroplacental blood flow and is a possible confounding factor which needs further evaluation. FUTURE PROSPECTS AND PROJECTS; In patients with antiphospholipid antibodies a higher impedance has been observed in the uterine artery, suggesting a possible vascular dysfunction precluding to impaired trophoblastic invasion and placental thrombosis, as probable mechanisms in the complications. If confirmed, these findings might have important implications for the management of these patients.


Revue de Médecine Interne | 2006

Mise au pointPrééclampsie et syndrome des antiphospholipides. Intérêt du Doppler utéroplacentairePreeclampsia and antiphospholipid syndrome. Uterine artery Doppler evaluation

Lionel Carbillon; M. Uzan; A. Kettaneh; Elisabeth Letellier; J. Stirnemann; Nicolas Perrot; A. Tigaizin; Olivier Fain

INTRODUCTIONnWomen with persistently high resistance in uterine arteries have an increased risk of the subsequent development of preeclampsia. Doppler investigation provides a non-invasive method for the study of the uteroplacental blood flow. In pregnant women the antiphospholipid syndrome is associated to an increased risk of preeclampsia and complications related to uteroplacental insufficiency, and the role of uterine artery Doppler is discussed.nnnCURRENT KNOWLEDGE AND KEY POINTSnIn normal pregnancy, impedance to flow in the uterine arteries decreases with gestation, as the likely consequence of the physiologic change of spiral arteries into low-resistance vessels. In women with preeclampsia or related complications, the abnormal persistence of high resistance to flow in the uterine arteries correlates with maternal and neonatal outcome. In one study including patients with antiphospholipid syndrome, a high resistance index in the uterine arteries at 22-24 weeks gestation strongly predicted the subsequent development of preeclampsia. In another study including patients with lupus anticoagulant, persistent bilateral notches at 22-24 weeks gestation may identify preeclampsia and fetal growth restriction with a high sensitivity, specificity, positive and negative predictive value. The treatment may improve the uteroplacental blood flow and is a possible confounding factor which needs further evaluation. FUTURE PROSPECTS AND PROJECTS; In patients with antiphospholipid antibodies a higher impedance has been observed in the uterine artery, suggesting a possible vascular dysfunction precluding to impaired trophoblastic invasion and placental thrombosis, as probable mechanisms in the complications. If confirmed, these findings might have important implications for the management of these patients.


Revue de Médecine Interne | 2008

Frquence de lallergie la pnicilline autodclare dans le dpartement de Seine-Saint-Denis

Albanne Branellec; M. Thomas; Olivier Fain; Adrien Kettaneh; J. Stirnemann; Elisabeth Letellier


Revue de Médecine Interne | 2006

Oxygnothrapie hyperbare danslacrise vaso-occlusive drpanocytaire

J. Stirnemann; Louis Brinquin; Elisabeth Letellier; N. Aras; S. Rouaghe; Gabriella Flexor; Marc Borne; Olivier Fain


Revue de Médecine Interne | 2006

Prclampsie etsyndrome desantiphospholipides. Intrt duDoppler utroplacentaire

Lionel Carbillon; Michele Uzan; Adrien Kettaneh; Elisabeth Letellier; J. Stirnemann; Nicolas Perrot; A. Tigaizin; Olivier Fain


Revue de Médecine Interne | 2006

Allergie lapnicilline auto-dclare dansledpartement deSeine-Saint Denis

A. Branellec; Elisabeth Letellier; J. Stirnemann; S. Rouaghe


Revue de Médecine Interne | 2006

Une arte depoisson mortelle

J. Stirnemann; Sophie Prevot; Elisabeth Letellier; S. Rouaghe; L. Boukari; Thorsten Braun; A. Kettaneh; Olivier Fain


Revue de Médecine Interne | 2005

Des lsions cutanes exubrantes au cours d'une infection par le VIH

Thorsten Braun; J. Stirnemann; F. Caux; A. Kettaneh; Elisabeth Letellier; Olivier Fain; M. Thomas


Journal of Cerebral Blood Flow and Metabolism | 2005

Influence of anaesthesia on the neuroprotective effect elicited by 3-aminobenzamide, a poly(ADP-ribose) polymerase inhibitor, in a mouse model of transient focal cerebral ischemia

Jérôme Y Couturier; Elisabeth Letellier; Bruno Palmier; Michel Plotkine; Isabelle Margaill


Revue de Médecine Interne | 2001

Pancytopénie périphérique et vascularite à ANCA :bonne réponse du traitement immunosuppresseur

Elisabeth Letellier; J. Cunningham; R.M. Feakins; G. R. V. Hughes; D P D'Cruz

Collaboration


Dive into the Elisabeth Letellier's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge